JP3515139B2 - Lectin purification method using lactitol - Google Patents
Lectin purification method using lactitolInfo
- Publication number
- JP3515139B2 JP3515139B2 JP04172693A JP4172693A JP3515139B2 JP 3515139 B2 JP3515139 B2 JP 3515139B2 JP 04172693 A JP04172693 A JP 04172693A JP 4172693 A JP4172693 A JP 4172693A JP 3515139 B2 JP3515139 B2 JP 3515139B2
- Authority
- JP
- Japan
- Prior art keywords
- lectin
- lactitol
- column
- purified
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090001090 Lectins Proteins 0.000 title claims description 66
- 102000004856 Lectins Human genes 0.000 title claims description 66
- 239000002523 lectin Substances 0.000 title claims description 66
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 title claims description 32
- 229960003451 lactitol Drugs 0.000 title claims description 29
- 235000010448 lactitol Nutrition 0.000 title claims description 29
- 239000000832 lactitol Substances 0.000 title claims description 29
- 238000000034 method Methods 0.000 title claims description 12
- 238000000746 purification Methods 0.000 title description 8
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000003480 eluent Substances 0.000 claims description 9
- 125000000524 functional group Chemical group 0.000 claims description 8
- KFEUJDWYNGMDBV-LODBTCKLSA-N N-acetyllactosamine Chemical group O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KFEUJDWYNGMDBV-LODBTCKLSA-N 0.000 claims description 6
- 238000001042 affinity chromatography Methods 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 3
- -1 β-D-galactosaminyl group Chemical group 0.000 claims description 3
- 125000002708 N-acetyl-beta-D-galactosaminyl group Chemical group C(C)(=O)N[C@H]1C(O[C@@H]([C@@H]([C@@H]1O)O)CO)* 0.000 claims description 2
- 125000001488 beta-D-galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 claims description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 9
- 238000000502 dialysis Methods 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000011543 agarose gel Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 5
- 240000001080 Grifola frondosa Species 0.000 description 5
- 235000007710 Grifola frondosa Nutrition 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 244000105624 Arachis hypogaea Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229920002684 Sepharose Polymers 0.000 description 4
- 239000003463 adsorbent Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- 235000010777 Arachis hypogaea Nutrition 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 108010046016 Peanut Agglutinin Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000004443 Ricinus communis Nutrition 0.000 description 2
- 240000000528 Ricinus communis Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000221377 Auricularia Species 0.000 description 1
- 240000003521 Bauhinia purpurea Species 0.000 description 1
- 235000011462 Bauhinia purpurea Nutrition 0.000 description 1
- 241000234542 Clitocybe nebularis Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000222684 Grifola Species 0.000 description 1
- 241001517511 Gymnothorax javanicus Species 0.000 description 1
- 241000995768 Ischnoderma Species 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 1
- 241000208720 Nepenthes Species 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 240000001462 Pleurotus ostreatus Species 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 125000002536 galactosaminyl group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000002373 hemiacetals Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HOVAGTYPODGVJG-VOQCIKJUSA-N methyl beta-D-galactoside Chemical compound CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-VOQCIKJUSA-N 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Landscapes
- Treatment Of Liquids With Adsorbents In General (AREA)
- Peptides Or Proteins (AREA)
Description
【0001】[0001]
【0002】本発明は、ラクチトールを用いたレクチン
の精製方法に関する。The present invention relates to a lectin purification method using lactitol.
【0003】[0003]
【0004】レクチンとは、糖と相互作用する蛋白質あ
るいは糖蛋白質であり、赤血球等の細胞を凝集させた
り、糖複合体を沈降させたりする特異な性質を持ってお
り、動物、植物、微生物などの殆どの生物種に存在して
いる。[0004] Lectin is a protein or glycoprotein that interacts with sugar and has a unique property of aggregating cells such as erythrocytes and precipitating a sugar complex. It is present in most species of.
【0005】レクチンは、主に細胞表面の顕微鏡的研究
のために使用されてきたが、近年になって、各種生物細
胞の制御や分化の機構に深く関与していることが見出さ
れ、ある種のレクチンにはアルツハイマー型痴呆症の予
防や治療への有効性が指摘されている神経成長因子の合
成を促進する働きがあることが判明するなど、その重要
な機能が明らかになりつつある。Lectins have been mainly used for microscopic studies on cell surfaces, but in recent years, they have been found to be deeply involved in the control and differentiation mechanisms of various biological cells, and It has been revealed that its important function is that various kinds of lectins have a function of promoting the synthesis of nerve growth factor, which has been pointed out to be effective for the prevention and treatment of Alzheimer-type dementia.
【0006】このような知見と共に、生物種に於けるレ
クチンの分布状況やそれらの性質についての研究が盛ん
に行われている。[0006] Along with such knowledge, studies on the distribution of lectins in biological species and their properties are being actively conducted.
【0007】それらのレクチンの中に、ガラクトピラノ
シル構造を含む官能基に対して結合する性質を有する一
群が知られているが、これらのレクチンを各種用途に使
用する際には、生物から抽出したレクチン含有物をその
まま使用すると、含まれる不純物の影響が発現すること
があるので、多くの場合、精製する必要がある。[0007] Among these lectins, a group having a property of binding to a functional group containing a galactopyranosyl structure is known, and when these lectins are used for various purposes, they are not isolated from organisms. If the extracted lectin-containing product is used as it is, the influence of impurities contained therein may be manifested, and in many cases, it needs to be purified.
【0008】レクチンを生物から得るには、適切な緩衝
液で抽出する方法が採用されるが、それを更に精製する
場合には、通常、硫安等による分画とレクチンが糖と結
合する性質を利用したアフィニティークロマトグラフィ
ー等が主な手法として採用される。To obtain a lectin from an organism, a method of extracting it with an appropriate buffer is adopted, but when it is further purified, the fraction by ammonium sulfate or the like and the property that the lectin binds to sugar are usually used. Affinity chromatography and the like used are mainly adopted.
【0009】特に、ガラクトピラノシル構造を含む官能
基に対して結合する性質を有するレクチンをアフィニテ
ィークロマトグラフィーに吸着させた後、その吸着材か
ら溶出する際に、溶出剤として従来から使用されていた
のは、D−ガラクトースやラクトースやメチル−β−D
−ガラクトピラノシドの水溶液であった。Particularly, when a lectin having a property of binding to a functional group containing a galactopyranosyl structure is adsorbed by affinity chromatography and then eluted from the adsorbent, it has been conventionally used as an eluent. Others are D-galactose, lactose and methyl-β-D
It was an aqueous solution of galactopyranoside.
【0010】[0010]
【0011】しかし、従来の方法には様々な課題が残さ
れていた。However, various problems remain in the conventional method.
【0012】例えば、メチル−β−D−ガラクトピラノ
シドは、試薬として市販されてはいるが、大量に消費さ
れるような用途が無いので、工業的な規模では生産され
ておらず、従って、このものを採用して目的物を得た場
合は、目的物のコストが極めて高価になると云う経済的
な課題があった。[0012] For example, methyl-β-D-galactopyranoside is commercially available as a reagent, but it is not produced on an industrial scale because it has no use in which it is consumed in a large amount. However, there is an economic problem that the cost of the object becomes extremely high when the object is obtained by adopting this material.
【0013】D−ガラクトースについても、比較的高価
であると云う経済的な課題と、このものはアルドースで
あり、水溶液にした場合に、アノマー、即ち、α体とβ
体の混合物になってしまうので、例えば、高速液体クロ
マトグラフィーでは2つのピークができる等の各種分析
の際に不都合なことが多いと云う課題があった。With respect to D-galactose, the economical problem that it is relatively expensive, and this is aldose, and when it is made into an aqueous solution, it is an anomer, that is, α-form and β-form.
Since it becomes a mixture of bodies, there is a problem that it is often inconvenient in various analyzes such as two peaks in high performance liquid chromatography.
【0014】また、ラクトースを使用した場合には、こ
のものが比較的安価なので、経済的な課題は解決できる
ものの、例えば、レクチンとの結合があまりにも強固に
なって溶出後のレクチン含有物からラクトースを除去し
にくい場合があると云う課題や、ガラクトースと同様に
各種分析の際に不都合があると云う課題が残されてい
た。Further, when lactose is used, it is relatively inexpensive, so that the economical problem can be solved, but, for example, the binding with lectin becomes too strong, and the lectin-containing substance after elution is used. There remains a problem that it is sometimes difficult to remove lactose, and a problem that it is inconvenient for various analyzes as with galactose.
【0015】従って、経済的に有利で、且つ、溶出後に
レクチン含有液から除去し易い物質を溶出剤として用い
たレクチンの精製方法の開発が要望されていたのであ
る。Therefore, there has been a demand for the development of a lectin purification method using a substance that is economically advantageous and that is easily removed from the lectin-containing liquid after elution as an eluent.
【0016】[0016]
【0017】本発明の課題を解決するための手段は、下
記の通りである。Means for solving the problems of the present invention are as follows.
【0018】本発明者等は、上記課題を解決するため
に、レクチンの挙動や各種吸着材の性質を鋭意研究し、
レクチンの精製の際に使用するアフィニティークロマト
グラフィーの溶出剤として食品用に大量に製造されてい
るラクチトールを採用することによって、前記課題を解
決することに成功し、本発明を完成させるに至った。In order to solve the above-mentioned problems, the inventors of the present invention have earnestly studied the behavior of lectins and the properties of various adsorbents,
By adopting lactitol, which is produced in large quantities for foods, as an eluent for affinity chromatography used in the purification of lectins, the above problems have been successfully solved and the present invention has been completed.
【0019】即ち、本発明は、下記の通りである。That is, the present invention is as follows.
【0020】第一の本発明は、D−ガラクトピラノシル
構造を含む官能基に対して結合する性質を有するレクチ
ンを精製するに際して、カラムクロマトグラフィーの溶
出剤としてラクチトール水溶液またはラクチトール含有
緩衝水溶液を用いることを特徴とするレクチンの精製方
法である。In the first aspect of the present invention, when a lectin having a property of binding to a functional group containing a D-galactopyranosyl structure is purified, an aqueous lactitol solution or an aqueous lactitol-containing buffer solution is used as an eluent for column chromatography. A method for purifying a lectin, which is characterized in that it is used.
【0021】第二の本発明は、D−ガラクトピラノシル
構造を含む官能基が、β−D−ガラクトピラノシル基、
β−D−ガラクトサミニル基、N−アセチル−β−D−
ガラクトサミニル基から成る群から選ばれる1種又は2
種以上である前記第一記載のレクチンの精製方法であ
る。In a second aspect of the present invention, the functional group containing a D-galactopyranosyl structure is a β-D-galactopyranosyl group,
β-D-galactosaminyl group, N-acetyl-β-D-
One or two selected from the group consisting of galactosaminyl groups
The method for purifying a lectin according to the above-mentioned first, which comprises at least one species.
【0022】以下に本発明の内容を詳細に説明する。The contents of the present invention will be described in detail below.
【0023】本発明に用いるレクチンは、D−ガラクト
ピラノシル構造を含む官能基に対して結合する性質を有
するものであれば何れも採用できるが、好ましくは、β
−D−ガラクトピラノシル基、β−D−ガラクトサミニ
ル基及び/又はN−アセチル−β−D−ガラクトサミニ
ル基に対して結合する性質を有するものが本発明を実施
した際に、クロマトカラムに対する吸着率が高く、ま
た、ラクチトールを用いて、カラムから容易に溶出され
ることや、その後の操作でラクチトールを容易に分離で
きること等の理由から、有利に採用することができる。The lectin used in the present invention may be any lectin as long as it has a property of binding to a functional group containing a D-galactopyranosyl structure, but β is preferred.
Adsorption to a chromatographic column when the present invention is carried out by a substance having a property of binding to a -D-galactopyranosyl group, a β-D-galactosaminyl group and / or an N-acetyl-β-D-galactosaminyl group. It can be advantageously used because it has a high rate and is easily eluted from the column by using lactitol, and lactitol can be easily separated by a subsequent operation.
【0024】D−ガラクトピラノシル構造を含む官能基
に対して結合する性質を有するレクチンとして知られて
いるものは数多く存在するが、その由来の例を挙げる
と、マッシュルーム(Agaricus bisporus )、ハイイロ
シメジ(Clitocybe nebularis)、ウラムラサキ(Lccar
ia amethystina )ヤニタケ(Ischnoderma resinosu
m)、マイタケ(Grifola frondosa)、ツリガネタケ(F
omes fomentarius )、アラゲキクラゲ(Auricularia p
olytricha)、ピーナッツ、(Arachis hypogaea)、ダ
イズ(Glycine max )、ヒマ(Ricinus communis)、モ
クワンジュ(Bauhinia purpurea )インゲンマメ(Phas
eolus vulgaris)、ドクウツボ(Gymnothorax javanicu
s )等がある。There are many known lectins having the property of binding to a functional group containing a D-galactopyranosyl structure, and examples of their origin include mushrooms (Agaricus bisporus) and gray Shimeji (Clitocybe nebularis), Uramurasaki (Lccar)
ia amethystina) Ischnoderma resinosu
m), Maitake (Grifola frondosa), Tsuriganetake (F
omes fomentarius), Araicularia jellyfish (Auricularia p)
olytricha), peanut, (Arachis hypogaea), soybean (Glycine max), castor bean (Ricinus communis), mokwanju (Bauhinia purpurea) common bean (Phas)
eolus vulgaris), Nepenthes (Gymnothorax javanicu)
s) etc.
【0025】本発明に採用するレクチンには、前記の制
約と、なるべく低温下で扱うことが好ましいと云う他に
は特に重大な制約は無く、生物体から抽出する際には、
多くの場合、被抽出物を細かく砕き、生物体と等張の生
理的食塩水やリン酸緩衝液等を用い、中性付近のpH
で、室温〜2℃程度のような条件が採用されるので、抽
出した後、通常は、そのままアガロースゲルカラム等の
アフィニティーカラムに室温〜2℃、通液速度SV[カ
ラム内の充填材容積(ml)に対する1時間あたりに通
液する液の容積(ml)]=0.01〜0.3程度で通
液してレクチンを選択的に吸着させることができる。The lectin used in the present invention has no particular serious restrictions other than the above-mentioned restrictions and that it is preferable to handle it at a temperature as low as possible.
In most cases, the extract is crushed into small pieces, and physiological saline or phosphate buffer that isotonic with the organism is used to adjust the pH to near neutral.
Since the conditions such as room temperature to 2 ° C. are adopted, after extraction, it is usually used as it is on an affinity column such as an agarose gel column at room temperature to 2 ° C., and the liquid flow rate SV [the packing material volume in the column ( It is possible to selectively adsorb the lectin by passing the liquid at a volume (ml) of about 0.01 to 0.3 per hour (ml).
【0026】しかし、本発明のカラムクロマトグラフィ
ーに採用するレクチンにガラクトース、ガラクトサミ
ン、N−アセチルガラクトサミン等が混入することは、
カラムに対するレクチンの吸着率を低下させることが多
いので、好ましくない。However, the fact that galactose, galactosamine, N-acetylgalactosamine, etc. are mixed in the lectin used in the column chromatography of the present invention,
It is not preferable because it often reduces the adsorption rate of the lectin to the column.
【0027】更に、本発明の実施の際にはカラムクロマ
トグラフィーが採用されるが、その充填剤としては、表
面にガラクトース残基が露出しているものが、該レクチ
ンの吸着率が高い等の理由から有利に採用可能であり、
例えば、市販のアガロースゲルや、各種基材の表面にガ
ラクトピラノシル構造を付加したもの等がある。Further, column chromatography is adopted in the practice of the present invention. As the packing material, those having galactose residues exposed on the surface have a high adsorption rate of the lectin. It can be advantageously adopted for the reason,
For example, there are commercially available agarose gels, those in which a galactopyranosyl structure is added to the surface of various base materials, and the like.
【0028】このアガロースゲルは、例えば、ファルマ
シア社のセファロースや、それを更に架橋させたセファ
ロースCLシリーズ等の名称でクロマト用試薬として市
販されているものをそのまま使用することもできるし、
市販のアガロースゲルを、3〜6Nの塩酸等で40〜5
0℃で数時間処理したもの等も、有利に採用可能であ
る。As this agarose gel, for example, Sepharose manufactured by Pharmacia, or Sepharose CL series obtained by further cross-linking it, which is commercially available as a reagent for chromatography, can be used as it is.
Use a commercially available agarose gel in 40-5 with 3-6N hydrochloric acid.
Those treated at 0 ° C. for several hours can also be advantageously used.
【0029】レクチンをカラムに吸着させた後、通常は
カラムを洗浄するが、その際の洗浄液は、抽出の際に使
用したと同様に、生体と等張の生理的食塩水やリン酸緩
衝液等を用いることが好ましく、カラムから出てきた液
の紫外部の吸収(UV)等を測定することにより洗浄が
終了したか否かを管理することができる。After the lectin is adsorbed on the column, the column is usually washed. The washing solution at that time is the same as that used in the extraction, such as physiological saline or phosphate buffer solution that is isotonic with the living body. Etc. are preferably used, and whether or not the washing is completed can be controlled by measuring the ultraviolet absorption (UV) of the liquid coming out of the column.
【0030】また、本発明にレクチンの溶出剤として用
いるラクチトールは、未還元成分が少ないものであれば
品質に特別の制約は無く、工業用途又は食品用途に製造
されている程度の品質で充分であり、結晶形について
も、無水結晶、一水和物結晶、二水和物結晶、三水和物
結晶の何れもが水溶液又は緩衝水溶液の形で有利に採用
できる。The lactitol used as the lectin eluent in the present invention has no particular restriction on the quality as long as it has a small amount of unreduced components, and it is sufficient that it is manufactured for industrial use or food use. As for the crystal form, any of anhydrous crystal, monohydrate crystal, dihydrate crystal and trihydrate crystal can be advantageously adopted in the form of an aqueous solution or a buffered aqueous solution.
【0031】溶出剤として用いるラクチトール水溶液又
はラクチトール含有緩衝水溶液中のラクチトール濃度
は、10〜500mM(ミリモル)程度にすることが、
レクチンに対する悪影響を最小限に留めるうえで好まし
い。The lactitol concentration in the aqueous lactitol solution or the aqueous lactitol-containing buffer solution used as the eluent is set to about 10 to 500 mM (mmol).
It is preferable for minimizing the adverse effect on the lectin.
【0032】また、通常の溶出操作の間、このラクチト
ール濃度は一定に保つことが好ましいが、必要に応じ
て、例えば、複数のレクチンをカラムに吸着させた後、
順次溶出したい場合は、ラクチトールの濃度を溶出開始
後の経過時間と共に変化させることも有利に行うことが
できる。It is preferable that the lactitol concentration be kept constant during the usual elution operation, but if necessary, for example, after adsorbing a plurality of lectins onto the column,
When it is desired to elute sequentially, it is also possible to advantageously change the concentration of lactitol with the elapsed time after the start of elution.
【0033】溶出剤の流速は、レクチンを吸着させた場
合と同様に、SV=0.01〜0.3程度とすること
が、ゲルを物理的に損なわないことや、通液量を必要以
上に増加させないこと等の理由から好ましい。The flow rate of the eluent is set to about SV = 0.01 to 0.3 as in the case of adsorbing the lectin so that the gel is not physically damaged and the flow rate is more than necessary. It is preferable because it is not increased.
【0034】また、溶出の終点を管理するには、前記の
洗浄操作の場合と同様に、溶出液のUV等を測定するこ
とによって行うことができる。The end point of elution can be controlled by measuring the UV or the like of the eluate as in the case of the above washing operation.
【0035】本発明の最大の特徴は、前記アガロース等
の吸着材カラムに吸着させたレクチンを、ラクチトール
水溶液又はラクチトール含有緩衝水溶液を用いて溶出さ
せることであるが、このラクチトールは、糖が還元され
てヘミアセタール環の一つが開いた形になっており、し
かもガラクトースの約2倍と、比較的分子量が大きく、
生体中に存在しないとされている。The greatest feature of the present invention is that the lectin adsorbed on the adsorbent column such as agarose is eluted with an aqueous lactitol solution or an aqueous lactitol-containing buffer solution. The lactitol is reduced in sugar. One of the hemiacetal rings is open, and the molecular weight is about twice that of galactose, which is relatively large.
It is said that it does not exist in the living body.
【0036】このようなラクチトールが生体中の物質で
あるレクチンに親和性を有し、且つそのレクチンを吸着
材から容易に溶出し得ることや、その後の操作でラクト
ースよりも除去しやすいと云うことは、生体物質に馴染
むものの多くは生体中に存在する物質であると云う通念
や、小さな分子のほうが透析膜を通過し易いこと等の常
識から見て、極めて意外なことであった。It is said that such lactitol has an affinity for lectin, which is a substance in the living body, and that the lectin can be easily eluted from the adsorbent, and that it is easier to remove than lactose by the subsequent operation. It was quite surprising from the general belief that most of the substances that are familiar with biological substances are substances that exist in the living body, and that common knowledge is that small molecules are more likely to pass through the dialysis membrane.
【0037】本発明を実施して得られたレクチンとラク
チトールの溶液は、この時点で、レクチン以外の生物体
由来の成分が殆ど除去されているので、場合によって
は、このままでも各種用途に供することができるが、必
要に応じて、混入しているラクチトールや緩衝剤として
用いたリン酸等を除去することも有利に実施できる。The solution of lectin and lactitol obtained by carrying out the present invention has almost all components derived from organisms other than lectins removed at this point, so depending on the case, it may be used for various purposes as it is. However, if necessary, it is also possible to advantageously carry out removal of contaminated lactitol, phosphoric acid used as a buffer, and the like.
【0038】本発明の方法によって得られたレクチンと
ラクチトールとの混合物からラクチトールを除去する手
法には、通常、レクチンの精製に用いられる方法が採用
可能であり、特に制約は無いが、例えば、透析等の手法
によれば、従来から糖を除去するために採用されていた
条件を適用するだけで、極めて容易に、ラクチトールを
ほぼ完全に除去することが可能である。As a method for removing lactitol from the mixture of lectin and lactitol obtained by the method of the present invention, a method usually used for purification of lectin can be adopted, and there is no particular limitation, but for example, dialysis According to such a method, it is possible to remove lactitol almost completely very easily by simply applying the conditions conventionally adopted for removing sugar.
【0039】[0039]
【0040】以下に、実施例を挙げて本発明の内容を更
に具体的に説明するが、本発明の範囲はこれらに限定さ
れるものではない。Hereinafter, the contents of the present invention will be described more specifically with reference to Examples, but the scope of the present invention is not limited to these.
【0041】また、以下の例の中では、%は特に断らな
い限り重量%を表すものとする。In the following examples,% means% by weight unless otherwise specified.
【0042】[実施例−1][Example-1]
【0043】過度に温度が高くならないように注意しな
がら、生のピーナッツ(Arachis hypogaea)20gを細
かく粉砕し、これに10ミリモル濃度(mM)、pH
7.4のリン酸緩衝液(PBS)50mlを加え、室温
にて3時間攪拌してレクチンを含む可溶成分を抽出し、
10,000Gで15分間遠心分離した後、その上澄液
を得た。次いで、試薬のクロマトグラフ用アガロースゲ
ル(ファルマシア社製、Sepharose-4B)50mlを充
填し、10mMのPBSで洗浄したカラムに、温度15
℃、流速6ml/hの条件で該上澄液を流し、その後、
UV吸収が観察されなくなるまで流速30ml/hで1
0mMのPBSを流し、カラムを洗浄した。更に、カラ
ムから出てくる液のUV吸収が観察されなくなるまで
0.2Mのラクチトール[東和化成工業(株)製、ミルヘ
ン]水溶液でレクチンを溶出し、溶出液を平均ポア径2
4Åの市販の透析膜(Viskase 社製、ダイアライシスメ
ンブラン)のチューブに入れ、時々水を交換しながら1
5℃の純水中で約18時間透析した。透析後の液を凍結
乾燥することにより、精製ピーナッツレクチン15mg
を得た。この精製ピーナッツレクチンは、分析の結果、
糖を全く含有しない精製度の高い品質であった。20 g of raw peanuts (Arachis hypogaea) were finely crushed, taking care not to raise the temperature excessively.
50 ml of phosphate buffer solution (PBS) of 7.4 was added and the mixture was stirred at room temperature for 3 hours to extract soluble components including lectin,
After centrifugation at 10,000 G for 15 minutes, the supernatant was obtained. Next, 50 ml of the chromatographic agarose gel (Pharmacia, Sepharose-4B), which was a reagent, was filled in the column and washed with 10 mM PBS at a temperature of 15
The supernatant at a temperature of 6 ° C. and a flow rate of 6 ml / h.
1 at a flow rate of 30 ml / h until no UV absorption is observed
The column was washed by flushing with 0 mM PBS. Further, the lectin was eluted with 0.2 M lactitol [Towa Kasei Kogyo Co., Ltd., Milchen] aqueous solution until UV absorption of the liquid coming out of the column was no longer observed, and the eluate had an average pore diameter of 2
Put it in a tube of 4 Å commercially available dialysis membrane (Viskase, Dialysis Membrane) and change the water occasionally.
It was dialyzed in pure water at 5 ° C. for about 18 hours. By freeze-drying the dialyzed solution, purified peanut lectin 15 mg
Got This purified peanut lectin was analyzed,
The quality of purification was high, containing no sugar.
【0044】[実施例−2][Example-2]
【0045】4℃の雰囲気下で、マイタケ(Grifola fr
ondosa)の子実体20gを細断し、50mMのEDTA
及び1mMの2−メルカプトエタノール混合液100m
lの中に入れて1夜攪拌した後、得られた懸濁液をガー
ゼで濾過し、ろ液を10,000Gで15分間遠心分離
した後、その上澄液を得た。上澄液に硫安を加えてゆ
き、30%飽和度〜80%飽和度で生成したレクチンを
含む沈殿を回収し、その沈殿を4℃の脱イオン水で透析
した後、凍結乾燥して、マイタケの粗レクチン46.8
mgを得た。3〜6Nの塩酸を用い、40〜50℃で2
時間酸処理して10mMのPBSで洗浄したクロマトグ
ラフ用アガロースゲル(ファルマシア社製、Sepharose
CL-4B)50mlを充填したカラムに、凍結乾燥品を
PBSに溶解した溶液を温度4℃、流速3ml/hの条
件で流し、その後、UV吸収が観察されなくなるまで流
速20ml/hで10mMのPBSを流し、カラムを洗
浄した。更に、カラムから出てくる液のUV吸収が観察
されなくなるまで50mMのラクチトール[東和化成工
業(株)製、ミルヘン]水溶液でレクチンを溶出し、溶出
液を限外ろ過膜で濃縮した後、平均ポア径24Åの市販
の透析膜(Viskase 社製、ダイアライシスメンブラン)
のチューブに入れ、時々水を交換しながら3℃の純水中
で約12時間透析した。透析後の液を凍結乾燥すること
により、マイタケの精製レクチン0.1mgを得た。こ
のマイタケの精製レクチンは、分析の結果、糖を全く含
有しない精製度の高い品質であった。In an atmosphere of 4 ° C., Maitake (Grifola fr
ondosa) fruit body 20g is shredded and 50mM EDTA
And 1 mM 2-mercaptoethanol mixed solution 100 m
The resulting suspension was filtered with gauze, the filtrate was centrifuged at 10,000 G for 15 minutes, and the supernatant was obtained. Ammonium sulfate was added to the supernatant to collect a lectin-containing precipitate formed at 30% to 80% saturation, and the precipitate was dialyzed against deionized water at 4 ° C., freeze-dried, and Maitake mushroom. Crude lectin 46.8
mg was obtained. Use 3-6N hydrochloric acid at 40-50 ° C for 2
Chromatographic agarose gel (Pharmacia, Sepharose) treated with acid for 10 hours and washed with 10 mM PBS
CL-4B) A column in which 50 ml was packed was run with a solution of the lyophilized product in PBS at a temperature of 4 ° C. and a flow rate of 3 ml / h, and then 10 mM at a flow rate of 20 ml / h until no UV absorption was observed. The column was washed by flushing PBS. Further, the lectin was eluted with 50 mM lactitol [Towa Kasei Co., Ltd., Milchen] aqueous solution until UV absorption of the liquid coming out of the column was not observed, and the eluate was concentrated with an ultrafiltration membrane, and then averaged. Commercially available dialysis membrane with a pore diameter of 24Å (Viskase, dialysis membrane)
It was put in a tube of No. 2 and dialyzed in pure water at 3 ° C. for about 12 hours while occasionally changing water. The dialyzed solution was lyophilized to obtain 0.1 mg of purified Lentinus edodes lectin. As a result of analysis, the purified lectin of Maitake was of a quality with a high degree of purification containing no sugar.
【0046】[実施例−3][Example-3]
【0047】5℃の雰囲気下で、ドクウツボ(Gymnotho
rax javanicus )の肝臓10gを粉砕し、0.9%の塩
化ナトリウム水溶液100mlの中に入れて1夜攪拌し
た後、得られた懸濁液をガーゼで濾過し、ろ液に硫安を
加えてゆき、80%飽和度で生成した沈殿を回収し、4
00mgの粗レクチンを得た。粗レクチンを10mlの
10mMPBSに溶解し、13,000Gで10分間遠
心分離した後、その上澄液を得た。上澄液を、10mM
のPBSで洗浄したクロマトグラフ用アガロースゲル
(ファルマシア社製、Sepharose CL- 4B)50mlを
充填したカラムに温度5℃、流速2ml/hの条件で流
し、その後、UV吸収が観察されなくなるまで流速30
ml/hで10mMのPBSを流し、カラムを洗浄し
た。更に、カラムから出てくる液のUV吸収が観察され
なくなるまで0.5Mのラクチトール[東和化成工業
(株)製、ミルヘン]水溶液でレクチンを溶出し、溶出液
を平均ポア径24Åの市販の透析膜(Viskase 社製、ダ
イアライシスメンブラン)のチューブに入れ、時々水を
交換しながら5℃の純水中で約10時間透析した。透析
後の液を凍結乾燥することにより、精製ドクウツボレク
チン0.2mgを得た。この精製ドクウツボレクチン
は、分析の結果、糖を全く含有しない精製度の高い品質
であった。Under an atmosphere of 5 ° C.,
10 g of liver of rax javanicus) was crushed, put in 100 ml of 0.9% sodium chloride aqueous solution and stirred overnight, and the obtained suspension was filtered with gauze, and ammonium sulfate was added to the filtrate. The precipitate formed at 80% saturation,
00 mg of crude lectin was obtained. The crude lectin was dissolved in 10 ml of 10 mM PBS and centrifuged at 13,000 G for 10 minutes to obtain the supernatant. The supernatant is 10 mM
Flow through a column packed with 50 ml of agarose gel for chromatography (Pharmacia, Sepharose CL-4B) washed with PBS at a temperature of 5 ° C and a flow rate of 2 ml / h, and then a flow rate of 30 until UV absorption is no longer observed.
The column was washed by flushing with 10 mM PBS at ml / h. Further, 0.5M lactitol [Towa Kasei Kogyo]
[Milchen Co., Ltd.] lectin was eluted with an aqueous solution, and the eluate was put into a tube of a commercially available dialysis membrane (Viskase, Dialysis Membrane) with an average pore diameter of 24 Å, and pure water at 5 ° C with occasional water exchange. It was dialyzed in water for about 10 hours. The dialyzed solution was freeze-dried to obtain 0.2 mg of purified dokutsubo lectin. As a result of the analysis, the purified doughnut lectin was of a highly purified quality containing no sugar.
【0048】[比較例−1][Comparative Example-1]
【0049】溶出剤としてラクチトールに代えてラクト
ースを用いた他は、実施例−2と同様にレクチンの抽出
・精製操作を行ってレクチンを得たが、分析の結果、糖
が検出され、レクチンの精製度は不充分であった。Lectin was extracted and purified in the same manner as in Example 2 except that lactose was used instead of lactitol as an eluent to obtain a lectin. As a result, sugar was detected and lectin was detected. The degree of purification was insufficient.
【0050】[試験例−1][Test Example-1]
【0051】常法によりプロナーゼ処理を施したO型ヒ
ト赤血球をアセテート緩衝等張液に3%濃度で懸濁させ
たものを用い、シグマ社のマイクロタイター・U−プレ
ートで、実施例−2で得られた粗レクチンと精製レクチ
ンの最低凝集濃度を測定して両者の1mgあたりの赤血
球凝集活性を算出した。その結果、粗レクチンの赤血球
凝集活性を1としたときの精製レクチンの活性は428
であった。この結果から、精製レクチンは、粗レクチン
に較べて活性成分が428倍に精製・濃縮されているこ
とが判る。In Example-2, a 0-type human erythrocyte treated with pronase was suspended in an acetate buffer isotonic solution at a concentration of 3% using a microtiter U-plate manufactured by Sigma. The minimum agglutination concentration of the obtained crude lectin and purified lectin was measured to calculate the hemagglutination activity per mg of both. As a result, the activity of the purified lectin was 428 when the hemagglutination activity of the crude lectin was set to 1.
Met. From this result, it is understood that the purified lectin has the active ingredient purified and concentrated by 428 times as compared with the crude lectin.
【0052】[0052]
【0053】本発明を実施することにより、従来の操作
に繁雑な操作を追加すること無く、経済的に有利に、し
かも、その後の操作で糖を除去し易いレクチン含有液を
得ることができる。By carrying out the present invention, it is possible to obtain a lectin-containing liquid which is economically advantageous and which is easy to remove sugar in the subsequent operation without adding a complicated operation to the conventional operation.
フロントページの続き (58)調査した分野(Int.Cl.7,DB名) C07K 1/00 C07K 14/42 CA(STN) BIOSIS/MEDLINE/WPID S(STN)Front page continued (58) Fields surveyed (Int.Cl. 7 , DB name) C07K 1/00 C07K 14/42 CA (STN) BIOSIS / MEDLINE / WPID S (STN)
Claims (2)
基に対して結合する性質を有するレクチンを精製するに
際して、アフィニティークロマトグラフィーの溶出剤と
してラクチトール水溶液またはラクチトール含有緩衝水
溶液を用いることを特徴とするラクチトールを用いたレ
クチンの精製方法。1. When purifying a lectin having a property of binding to a functional group containing a D-galactopyranosyl structure, a lactitol aqueous solution or a lactitol-containing buffer aqueous solution is used as an eluent for affinity chromatography. Method for purifying lectin using lactitol.
基が、β−D−ガラクトピラノシル基、β−D−ガラク
トサミニル基、N−アセチル−β−D−ガラクトサミニ
ル基から成る群から選ばれる1種又は2種以上である請
求項1記載のラクチトールを用いたレクチンの精製方
法。2. The functional group containing a D-galactopyranosyl structure is selected from the group consisting of a β-D-galactopyranosyl group, a β-D-galactosaminyl group and an N-acetyl-β-D-galactosaminyl group. The method for purifying lectin using lactitol according to claim 1, which is one kind or two or more kinds.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP04172693A JP3515139B2 (en) | 1993-02-08 | 1993-02-08 | Lectin purification method using lactitol |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP04172693A JP3515139B2 (en) | 1993-02-08 | 1993-02-08 | Lectin purification method using lactitol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH06234799A JPH06234799A (en) | 1994-08-23 |
| JP3515139B2 true JP3515139B2 (en) | 2004-04-05 |
Family
ID=12616433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP04172693A Expired - Fee Related JP3515139B2 (en) | 1993-02-08 | 1993-02-08 | Lectin purification method using lactitol |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3515139B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1415658A4 (en) * | 2001-07-16 | 2005-06-08 | Takara Bio Inc | REMEDIES |
| CN101817876B (en) * | 2010-03-26 | 2012-01-04 | 山东省花生研究所 | Method for purifying peanut seed agglutinin |
| CN111202880A (en) * | 2020-02-03 | 2020-05-29 | 深圳汉诺医疗科技有限公司 | Purifying column, device and method for purifying blood |
-
1993
- 1993-02-08 JP JP04172693A patent/JP3515139B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| J. Biol. Chem.,1977年,Vol.252, No.1,pp.57−60 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06234799A (en) | 1994-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5714354A (en) | Alcohol-free pneumococcal polysaccharide purification process | |
| AU590046B2 (en) | Tangential flow affinity ultrafiltration | |
| KR100286078B1 (en) | Purified Chitin Deacetylase | |
| Kaersgaard et al. | Antigenic beer macromolecules an experimental survey of purification methods | |
| JP3438735B2 (en) | Method for isolating human albumin from supernatant IV, especially IV-4 or corn fraction V or a similar supernatant or fraction | |
| JP3515139B2 (en) | Lectin purification method using lactitol | |
| US5811403A (en) | Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity | |
| CN1336434A (en) | Prepn. and affinity chromatographic purification process of kallidinogen enzyme | |
| SU1600633A3 (en) | Method of purifying protein toxin of bordetella petrusis bacteria | |
| Li et al. | Affinity chromatography of neoglycoproteins | |
| CN111808166A (en) | Yellow rice wine polypeptide prepared by a multistage separation and purification process and its application | |
| RU2225441C1 (en) | Method for preparing collagenase preparation | |
| Güran et al. | Isolation and properties of a lectin from the seeds of the Indian bean or lablab (Dolichos lablab L.) | |
| CN106946998A (en) | Natural antioxidant grifola frondosa polysaccharide CCPP-1 and preparation method and application thereof | |
| CN1071337C (en) | Purification process for hirudin using affinity chromatography | |
| WO1991018104A1 (en) | Indh enzyme compositions and their methods of use | |
| WO2000027876A1 (en) | Method for the isolation of lectins and the obtained purified lectins for use as a medicament | |
| Liengswangwong et al. | Basidiospore allergens: determination of optimal extraction methods | |
| El Rassi et al. | High-performance liquid chromatography of sialooligosaccharides and gangliosides | |
| Paulssen et al. | Purification of the antihemophilic factor by gel filtration on agarose | |
| JP3041598B2 (en) | Seaweed lectin and method for producing the same | |
| JP2826807B2 (en) | Seaweed lectin and method for producing the same | |
| Porath et al. | Biospecific methods for purification and characterization of pneumococcal polysaccharide PnS XIV | |
| JP4112236B2 (en) | Method for separating and purifying lectin, animal plasma immobilization carrier and affinity column | |
| CN120554438A (en) | A method for separating and purifying bird's nest glycoprotein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040113 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040115 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130123 Year of fee payment: 9 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130123 Year of fee payment: 9 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |